Junyuan Jerry Wang Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days, 17 hours ago

Junyuan Jerry Wang has an estimated net worth of at least $29.6 million*, as of Oct. 21, 2026. They own 6.1 million shares of NUVB stock. They have sold 56,361 shares of NUVB stock since 2021, for an estimated $162,883.

Junyuan Jerry Wang $NUVB SEC Form 4 Insider Trading

Junyuan Jerry Wang has filed a total of 1 insider trades in $NUVB since 2021. Their most recent trade was a sale of 56,361 shares, made on Nov 11, 2024. Their largest trade was a sale of 56,361 shares, made on Nov 11, 2024. We estimate that they now own 6.1 million shares of $NUVB, worth an estimated $29.4 million.

Insider Trading at $NUVB

There have been a total of 54 insider trades reported at $NUVB since 2021, with 7.9 million shares purchased and 8.5 million shares sold. The most active insider traders in $NUVB stock have been Dongfang Liu, Kerry Wentworth, and Gary Hattersley. The most recent trade was a sale of 100,000 shares reported by Gary Hattersley (CHIEF SCIENTIFIC OFFICER), made on Aug 19, 2026.

History of Insider Stock Trades by Junyuan Jerry Wang

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
NUVB	Sale	56,361	Nov 11, 2024	Nov. 13, 2024, 5:28 p.m.

$NUVB Executives and Stock Owners with Insider Trades

Dongfang Liu, CHIEF MEDICAL OFFICER
Kerry Wentworth, CHIEF REGULATORY OFFICER
Gary Hattersley, CHIEF SCIENTIFIC OFFICER
David Hung, PRESIDENT AND CEO
Philippe Sauvage, Chief Financial Officer
Stacy Markel, CHIEF PEOPLE OFFICER
Colleen Sjogren, Chief Commercial Officer
David C. Hanley, CHIEF TECHNICAL OPERATIONS
Junyuan Jerry Wang, CEO, ANHEART THERAPEUTICS LTD.

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.